1. Home
  2. HTZWW vs SRPT Comparison

HTZWW vs SRPT Comparison

Compare HTZWW & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hertz Global Holdings Inc Warrant

HTZWW

Hertz Global Holdings Inc Warrant

HOLD

Current Price

$2.50

Market Cap

0.0

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$22.90

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTZWW
SRPT
Founded
1918
1980
Country
United States
United States
Employees
26000
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.5B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
HTZWW
SRPT
Price
$2.50
$22.90
Analyst Decision
Hold
Analyst Count
0
28
Target Price
N/A
$25.40
AVG Volume (30 Days)
87.5K
3.2M
Earning Date
02-13-2025
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,049,000,000.00
$2,198,237,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.58
52 Week Low
$1.90
$10.42
52 Week High
$4.98
$64.80

Technical Indicators

Market Signals
Indicator
HTZWW
SRPT
Relative Strength Index (RSI) 60.85 64.87
Support Level N/A $20.61
Resistance Level $2.73 $23.51
Average True Range (ATR) 0.17 1.30
MACD 0.06 0.59
Stochastic Oscillator 90.63 85.75

Price Performance

Historical Comparison
HTZWW
SRPT

About HTZWW Hertz Global Holdings Inc Warrant

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through its Hertz, Dollar and Thrifty brands. The company has two reportable segments: i) Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean, ii) International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The company maintains a substantial network of company-operated rental locations, a majority of which are in Europe, and has franchisees and partners that operate rental locations under brands. Geographical markets include North America, Europe, Pacific Asia, Middle East and Africa, and Latin America.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: